HIV/AIDS seroincidence/seroprevalence studies from Africa.
Adubofour
K
K
D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000191:economics / Q000453:epidemiology* / Q000517:prevention & control; D015528:HIV Seroprevalence; D006801:Humans; D015994:Incidence; D012432:Rwanda / Q000453:epidemiology